Prothena Corp Public (PRTA) Net Income towards Common Stockholders Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) Net Income towards Common Stockholders Growth (5y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Prothena Corp Public |
479.08 Mn |
149.61 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
23.65% |
| Dec 31, 2025 |
6.81% |
| Sep 30, 2025 |
-3.61% |
| Jun 30, 2025 |
-36.77% |
| Mar 31, 2025 |
-20.66% |
| Dec 31, 2024 |
-21.89% |
| Sep 30, 2024 |
-24.85% |
| Jun 30, 2024 |
44.17% |
| Mar 31, 2024 |
-28.20% |
| Dec 31, 2023 |
-24.60% |
| Sep 30, 2023 |
23.67% |
| Jun 30, 2023 |
1.83% |
| Mar 31, 2023 |
0.78% |
| Dec 31, 2022 |
16.36% |
| Sep 30, 2022 |
2.69% |
| Jun 30, 2022 |
-18.45% |
| Mar 31, 2022 |
-0.51% |
| Dec 31, 2021 |
7.47% |
| Sep 30, 2021 |
35.26% |
| Jun 30, 2021 |
21.82% |
